Literature DB >> 26756582

Maleimide-Functionalized Poly(2-Oxazoline)s and Their Conjugation to Elastin-Like Polypeptides.

Jonas F Nawroth1, Jonathan R McDaniel2, Ashutosh Chilkoti2, Rainer Jordan1, Robert Luxenhofer1.   

Abstract

The design of drug delivery systems capable of efficiently delivering poorly soluble drugs to target sites still remains a major challenge. Such materials require several different functionalities; typically, these materials should be biodegradable and nontoxic, nonimmunogenic, responsive to their environment, and soluble in aqueous solution while retaining the ability to solubilize hydrophobic drugs. Here, a polypeptide-polymer hybrid of elastin-like polypeptides (ELPs) and poly(2-oxazoline)s (POx) is reported. This paper describes the chemical synthesis, physical characteristics, and drug loading potential of these novel hybrid macromolecules. A novel method is introduced for terminal functionalization of POx with protected maleimide moieties. Following recovery of the maleimide group via a retro Diels-Alder reaction, the consecutive Michael addition of thiol-functionalized ELPs yields the desired protein-polymer conjugate. These conjugates form nanoparticles in aqueous solution capable of solubilizing the anti-cancer drug paclitaxel with up to 8 wt% loading.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bioconjugation; drug delivery systems; elastin-like polypeptides; paclitaxel; ring-opening polymerization

Mesh:

Substances:

Year:  2016        PMID: 26756582      PMCID: PMC5320936          DOI: 10.1002/mabi.201500376

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  33 in total

Review 1.  New methods of drug delivery.

Authors:  R Langer
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

2.  Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility.

Authors:  Marius Bauer; Christian Lautenschlaeger; Kristian Kempe; Lutz Tauhardt; Ulrich S Schubert; Dagmar Fischer
Journal:  Macromol Biosci       Date:  2012-05-30       Impact factor: 4.979

3.  Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.

Authors:  XinYu Wang; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  J Control Release       Date:  2007-02-24       Impact factor: 9.776

Review 4.  Preclinical and clinical studies of anticancer agent-incorporating polymer micelles.

Authors:  Yasuhiro Matsumura; Kazunori Kataoka
Journal:  Cancer Sci       Date:  2009-04       Impact factor: 6.716

5.  A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.

Authors:  Zhijian He; Lei Miao; Rainer Jordan; Devika S-Manickam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2015-04-02       Impact factor: 4.979

6.  HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.

Authors:  Tomás Etrych; Milada Sírová; L Starovoytova; Blanka Ríhová; Karel Ulbrich
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

7.  Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.

Authors:  Gene L Bidwell; Izabela Fokt; Waldemar Priebe; Drazen Raucher
Journal:  Biochem Pharmacol       Date:  2006-11-10       Impact factor: 5.858

8.  Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation.

Authors:  Tao Yang; Fu-De Cui; Min-Koo Choi; Jei-Won Cho; Suk-Jae Chung; Chang-Koo Shim; Dae-Duk Kim
Journal:  Int J Pharm       Date:  2007-02-13       Impact factor: 5.875

9.  Poly(2-oxazoline) hydrogels for controlled fibroblast attachment.

Authors:  Brooke L Farrugia; Kristian Kempe; Ulrich S Schubert; Richard Hoogenboom; Tim R Dargaville
Journal:  Biomacromolecules       Date:  2013-07-29       Impact factor: 6.988

10.  A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models.

Authors:  Jayanta Bhattacharyya; Joseph J Bellucci; Isaac Weitzhandler; Jonathan R McDaniel; Ivan Spasojevic; Xinghai Li; Chao-Chieh Lin; Jen-Tsan Ashley Chi; Ashutosh Chilkoti
Journal:  Nat Commun       Date:  2015-08-04       Impact factor: 14.919

View more
  4 in total

1.  Responsive Hybrid (Poly)peptide-Polymer Conjugates.

Authors:  Bradford A Paik; Shivshankar R Mane; Xinqiao Jia; Kristi L Kiick
Journal:  J Mater Chem B       Date:  2017-10-06       Impact factor: 6.331

2.  Temperature-Dependent Rheological and Viscoelastic Investigation of a Poly(2-methyl-2-oxazoline)-b-poly(2-iso-butyl-2-oxazoline)-b-poly(2-methyl-2-oxazoline)-Based Thermogelling Hydrogel.

Authors:  Michael M Lübtow; Miroslav Mrlik; Lukas Hahn; Alexander Altmann; Matthias Beudert; Tessa Lühmann; Robert Luxenhofer
Journal:  J Funct Biomater       Date:  2019-08-07

3.  Synthesis of Poly(Malic Acid) Derivatives End-Functionalized with Peptides and Preparation of Biocompatible Nanoparticles to Target Hepatoma Cells.

Authors:  Clarisse Brossard; Manuel Vlach; Elise Vène; Catherine Ribault; Vincent Dorcet; Nicolas Noiret; Pascal Loyer; Nicolas Lepareur; Sandrine Cammas-Marion
Journal:  Nanomaterials (Basel)       Date:  2021-04-09       Impact factor: 5.076

4.  Maleimide end-functionalized poly(2-oxazoline)s by the functional initiator route: synthesis and (bio)conjugation.

Authors:  Gabriela Gil Alvaradejo; Mathias Glassner; Richard Hoogenboom; Guillaume Delaittre
Journal:  RSC Adv       Date:  2018-03-05       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.